Following from research on firms' upper echelons, this article examines the previously unstudied issue of how technological dynamism moderates the relationship between a CEO's time in office and company inventive activities. We evaluate this relationship in the biopharmaceutical industry, a technology- and invention-intensive context. As would be expected from notions of a CEO life cycle, our results indicate a curvilinear, inverted U-shaped overall relationship between CEO tenure and invention. But technological dynamism shifts this curve in such a way that short-tenured CEOs engender more invention under highly dynamic technological environments, while long-tenured CEOs spur greater invention under more stable technologies.
No takes yet. Share an insight, caveat, or question.
Wu et al. (2005) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: